Bristol Myers Squibb

Biopharmaceutical research and medicines

Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for people with serious diseases. Its work combines in-house research with external partnerships and includes oncology, hematology, cardiology, and multiple sclerosis.

Presence in Spain

The company operates in Spain through Bristol-Myers Squibb, S.A.U. and maintains communication channels for patients, caregivers, health care professionals, and researchers. Its facilities include CITRE, an R&D center in Seville described as a pioneer in hematology research and the identification of new therapeutic targets.

Research and public information

• Oncology and hematology.
• Cardiomyopathies, including the “Cardiomyopathies Matter” campaign and a technology-innovation project with Tucuvi.
• Relapsing-remitting multiple sclerosis, including the EMpoderarTE campaign.
• Joint health, through the “Comorbidities and Joint Health” initiative.
• Continuing education for health care professionals.

Corporate information

The company publishes an ESG report and maintains a preventive policy and an integrity line. It is on LinkedIn, X as BMSIberia, and YouTube as BMSIberia. For European Union data-protection inquiries, it lists EUDPO@BMS.com.